EUVIMEDEUVIMED entdecken
Open Access

Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024

Ariana P Toepfer, Rachel E Rutkowski, Leila C Sahni, Geoffrey A Weinberg, Marian G Michaels, Rangaraj Selvarangan, Mary Allen Staat, Natasha Halasa, Janet A Englund, Julie A Boom, Peter G Szilagyi, Jennifer E Schuster und 9 weitere

JAMA Network Open · 2025

DOI: 10.1001/jamanetworkopen.2025.31499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, 2025. Verfasst von Ariana P Toepfer und 20 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Respiratory Syncytial Virus Infections, COVID-19 Testing. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCIRD CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Studies of COVID-19, influenza, and respiratory syncytial virus (RSV) disease clinical epidemiology, disease burden, and vaccine effectiveness often rely on clinical testing to identify cases, particularly with increasing use of electronic health record data. However, few data are available describing clinical testing practices to inform interpretation of these studies.

Objective

To characterize clinical testing frequency for SARS-CoV-2, influenza, and RSV among children and adolescents hospitalized with acute respiratory illness during the 2016 to 2024 respiratory illness seasons by age, intensive care unit admission, and time period (2016-2020 and each season in 2020-2024); estimate the case fraction missed by clinical testing alone; and identify patient characteristics associated with clinical testing. Design, Setting, and Participants This cross-sectional study analyzed data collected through prospective surveillance with systematic molecular testing (surveillance testing) for SARS-CoV-2, influenza viruses, and RSV among children and adolescents younger than 18 years hospitalized with acute respiratory illness at 6 US medical centers during the winter respiratory illness seasons of 2016 to 2024. In-hospital clinical molecular testing data were abstracted from the medical record. Main Outcomes and Measures The proportion of children and adolescents with clinical molecular testing for SARS-CoV-2, influenza viruses, and RSV.

Results

During 2016 to 2024, a total of 26 073 hospitalized youths were enrolled (14 459 aged <2 years [55.5%]; 14 833 male [56.9%]), including 12 090 youths during 2016 to 2020 combined. Overall, 10 450 youths (40.1%) had an underlying medical condition. The proportion of youths with clinical testing decreased for SARS-CoV-2 from 3965 of 4388 youths (90.4%) during 2020 to 2021 to 2802 of 3685 youths (76.0%) during 2023 to 2024 ( P < .001). In contrast, clinical testing increased from the 2016 to 2020 seasons to the 2023 to 2024 season for influenza viruses (5384 of 12 090 youths [44.5%] to 2740 of 3685 youths [74.4%]; P < .001) and RSV (5072 youths [42.0%] to 2638 youths [71.6%]; P < .001). During the 2023 to 2024 season, the proportion of youths identified as positive for each virus by surveillance testing alone (ie, without clinical testing) was 23 of 112 youths (20.5%) for SARS-CoV-2, 78 of 286 youths (27.3%) for influenza, and 290 of 979 youths (29.6%) for RSV; youths were more likely to receive clinical testing if they were admitted to the intensive care unit (eg, SARS-CoV-2: adjusted odds ratio [aOR], 2.62; 95% CI, 2.06-3.33) or had underlying conditions (eg, any vs no underlying condition for SARS-CoV-2: aOR, 1.56; 95% CI, 1.33-1.84). Conclusions and Relevance In this study, SARS-CoV-2 clinical testing decreased between 2020 to 2021 and 2023 to 2024 seasons, whereas influenza and RSV testing increased significantly between 2016 to 2020 and 2023 to 2024 seasons; approximately three-quarters of children and adolescents were tested for the 3 viruses in 2023 to 2024.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanCOVID-19Respiratory Syncytial Virus InfectionsCOVID-19 TestingHumansAdolescentMaleChildFemaleChild, PreschoolCross-Sectional StudiesInfantHospitalizationSARS-CoV-2United StatesProspective StudiesInfant, Newborn

Autor:innen und Institutionen

  • National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Texas Children's Hospital, Houston.
  • Department of Pediatrics, Baylor College of Medicine.
  • Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, New York.
  • Department of Pediatrics University of Pittsburgh School of Medicine (UPMC), UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
  • Children's Mercy, Kansas City, Missouri.

Förderung

  • NCIRD CDC HHS

Zitieren

APA

Toepfer, A. P., Rutkowski, R. E., Sahni, L. C., Weinberg, G. A., Michaels, M. G., Selvarangan, R., Staat, M. A., Halasa, N., Englund, J. A., Boom, J. A., Szilagyi, P. G., Schuster, J. E., Schlaudecker, E. P., Stewart, L. S., Klein, E. J., Olson, S. M., Ellington, S., McMorrow, M. L., Moline, H. L., …, & New Vaccine Surveillance Network Collaborators (2025). Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.31499

Vancouver

Toepfer AP, Rutkowski RE, Sahni LC, Weinberg GA, Michaels MG, Selvarangan R, et al. Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.31499

BibTeX
@article{Toepfer2025,
  author = {Toepfer, Ariana P and Rutkowski, Rachel E and Sahni, Leila C and Weinberg, Geoffrey A and Michaels, Marian G and Selvarangan, Rangaraj and Staat, Mary Allen and Halasa, Natasha and Englund, Janet A and Boom, Julie A and Szilagyi, Peter G and Schuster, Jennifer E and Schlaudecker, Elizabeth P and Stewart, Laura S and Klein, Eileen J and Olson, Samantha M and Ellington, Sascha and McMorrow, Meredith L and Moline, Heidi L and Dawood, Fatimah S and New Vaccine Surveillance Network Collaborators, New Vaccine Surveillance Network Collaborators},
  title = {Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024},
  journal = {JAMA Network Open},
  year = {2025},
  doi = {10.1001/jamanetworkopen.2025.31499}
}
Kostenlos starten →